Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer

NCT00634634 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
52
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Rutgers, The State University of New Jersey

Collaborators